Toxocara spp. seronegativity in Czech patients with early form of multiple sclerosis clinically isolated syndrome

被引:0
|
作者
Posova, H. [1 ,2 ]
Hruskova, Z. [1 ,2 ]
Havrdova, E. [2 ,3 ]
Kolarova, L. [1 ,2 ]
机构
[1] LF UK, Ustav Imunol & Mikrobiol 1, Prague, Czech Republic
[2] VFN Praha, Prague, Czech Republic
[3] LF UK, Neurol Klin, Prague, Czech Republic
来源
EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE | 2017年 / 66卷 / 03期
关键词
multiple sclerosis; Toxocara; eosinophilia; clinically isolated syndrome; HELMINTHS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Helminth infections were reported to slightly modulate the host immune system response and decrease the risk of an autoimmune disorder, but on the other hand any infection may activate the immune system and trigger autoimmune reaction. In this study, we aimed to measure eosinoohil levels and antibodies against Toxocara spp. in patients with clinically isolated syndrome (CIS) and multiple sclerosis (MS). Methods: In total. 220 CIS patients and 62 MS patients were examined. Antibodies against Toxocara secretory/excretory antigens (TES) were measured with an ELISA method. Results: A total of 1,983 measurements of eosinophil levels were performed in CIS patients, out of which 95 results in 21 different patients were above the upper normal limit of the laboratory, but it was mostly only a relative increase. Two patients showed eosinophil levels above 20 but both of them suffered from severe allergy. None of the CIS patients had any clinical signs of parasitic infections and the serological tests for antibodies against Toxocara were all negative. In all MS patients, eosinoohil levels were in normal range. Antibodies against TES were detected in only 1 out of 62 (1.6%) MS patients. Conclusions: Based on our results it does not seem that Toxocara infection reoresents a potential trigger of MS. Nevertheless, our study indirectly confirms the hypothesis that parasitic infection may protect from autoimmunity.
引用
收藏
页码:124 / 127
页数:4
相关论文
共 50 条
  • [31] Developmental Venous Anomalies are More Common in Patients with Multiple Sclerosis and Clinically Isolated Syndrome Coincidence or Relevant?
    Kruczek, Patrick
    Bellenberg, Barbara
    Lutz, Theodor
    Schneider, Ruth
    Ahlborn, Christian
    Gold, Ralf
    Koester, Odo
    Lukas, Carsten
    CLINICAL NEURORADIOLOGY, 2021, 31 (01) : 225 - 234
  • [32] White matter and deep gray matter hemodynamic changes in multiple sclerosis patients with clinically isolated syndrome
    Papadaki, Efrosini Z.
    Mastorodemos, Vasileios C.
    Amanakis, Emmanouil Z.
    Tsekouras, Konstantinos C.
    Papadakis, Antonis E.
    Tsavalas, Nikolaos D.
    Simos, Panagiotis G.
    Karantanas, Apostolos H.
    Plaitakis, Andreas
    Maris, Thomas G.
    MAGNETIC RESONANCE IN MEDICINE, 2012, 68 (06) : 1932 - 1942
  • [33] Analysis of apoptosis-related genes in patients with clinically isolated syndrome and their association with conversion to multiple sclerosis
    Hagman, Sanna
    Kolasa, Marcin
    Basnyat, Pabitra
    Helminen, Mika
    Kahonen, Mika
    Dastidar, Prasun
    Lehtimaki, Terho
    Elovaara, Irina
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 280 : 43 - 48
  • [34] Oxylipins in cerebrospinal fluid in clinically isolated syndrome and relapsing remitting multiple sclerosis
    Hakansson, Irene
    Gouveia-Figueira, Sandra
    Ernerudh, Jan
    Vrethem, Magnus
    Ghafouri, Nazdar
    Ghafouri, Bijar
    Nording, Malin
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2018, 138 : 41 - 47
  • [35] Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis
    Hynicova, Eva
    Vyhnalek, Martin
    Kalina, Adam
    Martinkovi, Lukas
    Nikolai, Tomas
    Lisy, Jiri
    Hort, Jakub
    Meluzinova, Eva
    Laczo, Jan
    JOURNAL OF NEUROLOGY, 2017, 264 (03) : 482 - 493
  • [36] Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function
    Marcos-Ramiro, Beatriz
    Oliva Nacarino, Pedro
    Serrano-Pertierra, Esther
    Angel Blanco-Gelaz, Miguel
    Weksler, Babette B.
    Romero, Ignacio A.
    Couraud, Pierre O.
    Tunon, Alberto
    Lopez-Larrea, Carlos
    Millan, Jaime
    Cernuda-Morollon, Eva
    BMC NEUROSCIENCE, 2014, 15
  • [37] Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome
    Deretzi, G.
    Gavalas, E.
    Boziki, M.
    Tsiptsios, D.
    Polyzos, S. A.
    Venizelos, I.
    Zavos, C.
    Koutlas, E.
    Tsiptsios, I.
    Katsinelos, P.
    Kountouras, J.
    ACTA NEUROLOGICA SCANDINAVICA, 2016, 133 (04): : 268 - 275
  • [38] Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis
    Eva Hynčicová
    Martin Vyhnálek
    Adam Kalina
    Lukáš Martinkovič
    Tomáš Nikolai
    Jiří Lisý
    Jakub Hort
    Eva Meluzínová
    Jan Laczó
    Journal of Neurology, 2017, 264 : 482 - 493
  • [39] Progression predictors of clinically isolated syndrome to multiple sclerosis: A prospective study in China
    Qiu, Xiaohui
    Liang, Yeyuan
    Wei, Yunfei
    Lu, Mengru
    Mei, Yujia
    Liu, Bo
    Tang, Yulan
    Liang, Junli
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 245
  • [40] Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis
    Crnosija, Luka
    Adamec, Ivan
    Lovric, Mila
    Junakovic, Anamari
    Skoric, Magdalena Krbot
    Lusic, Ivo
    Habek, Mario
    CLINICAL NEUROPHYSIOLOGY, 2016, 127 (01) : 864 - 869